A breakdown of immune tolerance resulting in T cell- and B cell-mediated attacks against self-tissues, characterized by chronic inflammation, tissue destruction, and excessive cell proliferation. Includes conditions like Psoriasis, rheumatoid arthritis, Multiple Sclerosis, Type 1 diabetes, and Hashimoto's thyroiditis. The pathology emerges from the convergence of genetic susceptibility (HLA antigens), Epigenetic Modifications, environmental triggers (infections, toxins, dietary antigens), and Evolutionary mismatch.
Imagine a military base with two security checkpoints: the training academy (thymus) and the field checkpoint (peripheral tissues). During training, new soldiers (T cells) must prove they won't attack their own citizens (Self-Associated Molecular Pattern). Most learn correctly, but a few recruits who show hostility to citizens are supposed to be dismissed or converted to peacekeepers (Treg cells).
In autoimmune disease, this quality control fails at both checkpoints. Aggressive recruits graduate from training, and field supervisors who should stop them are either absent or ineffective. Meanwhile, enemy spies (viruses, bacteria) wear citizen uniforms—a trick called Molecular Mimicry—confusing the soldiers into attacking real citizens. The perimeter wall (gut barrier) has holes from Intestinal permeability, allowing enemy agents and weapons (Endotoxaemia, bacterial translocation) to constantly sneak in, keeping the base on permanent high alert. The soldiers start calling in reinforcements (TNF-α, IL-17, IFN-γ) that carpet-bomb entire neighborhoods (tissues), destroying friend and foe alike. The alarm system (inflammatory cytokines) never turns off, and the constant warfare exhausts everyone—but the soldiers keep fighting because their orders (inflammatory memory) say the threat never ends.
Autoimmune disease requires failure of both central and peripheral tolerance mechanisms, creating a multi-step pathway to tissue destruction:
Central Tolerance Failure:
- In thymus, autoreactive T cells expressing T cell receptors (TCR) with high affinity for self-antigens presented by HLA antigens (MHC) should undergo negative selection (apoptosis)
- AIRE (autoimmune regulator) gene expression in thymic medullary epithelial cells normally presents tissue-restricted antigens to eliminate autoreactive clones
- Genetic variants in HLA (e.g., HLA-B27 in Ankylosing spondylitis, HLA-DRB1 in rheumatoid arthritis) reduce negative selection efficiency
- Escaped autoreactive T cells (both CD4+ and CD8+) enter peripheral circulation
Peripheral Tolerance Breakdown:
Molecular Mimicry Activation:
graph TD
A["Infection: EBV, Streptococcus, P. gingivalis"] --> B[Pathogen epitopes share sequence homology with self-antigens]
B --> C[T cell activation via TCR cross-reactivity]
C --> D["Epitope spreading: immune response broadens to other self-epitopes"]
D --> E[Chronic autoreactive immune response]
E --> F[Tissue damage releases more self-antigens]
F --> D
Inflammatory Cascade:
- Activated autoreactive T cells produce IFN-γ → macrophage activation → TNF-α production
- Th17 cells produce IL-17A/F, IL-22 → neutrophil recruitment, keratinocyte proliferation (in Psoriasis)
- IL-23 (from dendritic cells) maintains Th17 differentiation and survival
- NF-kB activation in tissue cells → expression of adhesion molecules (VCAM-1, ICAM-1) → leukocyte infiltration
- COX-2 → Prostaglandin E2 → pain sensitization and vasodilation
- Chronic TNF-α exposure → Cytokine resistance via upregulation of SOCS3 → paradoxically higher inflammation to achieve same regulatory effect
Tissue-Specific Mechanisms:
Metabolic Amplification:
Autoimmune diseases represent the clinical endpoint of multiple Evolutionary mismatch factors converging on immune dysregulation. In cPNI practice, they serve as visible manifestations of deeper systems failures across all five metamodels.
Model Disease - Psoriasis:
Psoriasis serves as the teaching model in cPNI because inflammatory activity is visible on skin, making treatment response immediately observable. The condition demonstrates all core autoimmune mechanisms: T cell activation (plaque biopsy shows CD4+/CD8+ infiltration), excessive proliferation (keratinocytes), cytokine networks (IL-23/IL-17 axis measurable in serum), and metabolic dysfunction (60-80% have metabolic syndrome). Treatment success requires addressing all five systems simultaneously.
Evolutionary Mismatch Drivers:
Clinical Thresholds:
- CRP >10 mg/L indicates active systemic inflammation requiring intervention
- Anti-CCP antibodies >20 U/mL highly specific for rheumatoid arthritis (95% specificity)
- TNF-α >8 pg/mL correlates with disease activity in multiple autoimmune conditions
- IL-6 >10 pg/mL associated with increased cardiovascular risk in autoimmune patients
- Vitamin D <30 ng/mL associated with increased autoimmune disease risk and activity
Intervention Hierarchy (5+2 Metamodel):
- Barrier restoration: Heal Intestinal permeability with L-glutamine, zinc carnosine, collagen peptides
- Pathogen clearance: Address chronic infections (EBV, Porphyromonas gingivalis) that maintain Molecular Mimicry
- Metabolic optimization: Intermittent fasting, cold exposure, Exercise to restore Insulin resistance and mitochondrial function
- Stress axis repair: HPA axis modulation through sleep optimization, Meditation, adaptogenic herbs
- Environmental medicine: Assess noise, light (especially blue light at night), chemical exposures affecting insular cortex immune signaling
Special Population - Down Syndrome:
Patients with Down syndrome (Trisomy 21) show 850 kcal/day basal metabolic rate vs. 1400-1800 kcal/day in typical adults, reflecting altered mitochondrial function and reduced thyroid sensitivity. They have 50% higher autoimmune disease prevalence (thyroiditis, celiac, diabetes) due to chromosome 21 carrying immune-regulatory genes (interferon receptors, SOD1). Treatment requires careful metabolic calibration—standard caloric recommendations cause weight gain and worsen autoimmune inflammation.
Insular Cortex Integration:
The insular cortex acts as immune system integrator, receiving signals from peripheral immune activation (vagal afferents carry IL-1β, TNF-α information) and modulating HPA axis and autonomic responses. Dysfunction here (measurable via fMRI connectivity studies) correlates with disease severity across autoimmune conditions. Interoceptive training (mindfulness, body scanning, breathing exercises) can restore insular function and reduce autoimmune flares.
- Psoriasis used as cPNI demonstration model because inflammatory plaques provide visible treatment feedback—skin clearing indicates successful immune modulation
- Central tolerance failure in thymus allows 1-5% of autoreactive T cells to escape; normally suppressed by peripheral Treg cells
- HLA antigens confer disease risk: HLA-B27 (90% of Ankylosing spondylitis), HLA-DRB1*04:01 (4-fold increased rheumatoid arthritis risk)
- Molecular Mimicry between Streptococcus M protein and cardiac myosin causes Rheumatic Fever—classic example of infection-triggered autoimmunity
- PAD-4 activation by smoking, infections, or inflammation converts arginine→citrulline in proteins, creating neoantigens recognized by ACPA in rheumatoid arthritis
- Citrullinated proteins antibodies (ACPA) appear 5-10 years before clinical rheumatoid arthritis symptoms—earliest biomarker available
- Intestinal permeability measured by lactulose/mannitol ratio; >0.03 indicates barrier dysfunction allowing Endotoxaemia
- Dehydration-triggered AVP chronically elevated in many autoimmune patients contributes to hypertension (present in 40-60% of autoimmune cohorts)
- Down syndrome patients (Trisomy 21) have 50% viability rate, 850 kcal/day BMR, and dramatically increased autoimmune disease prevalence due to immune gene dosage imbalance
- IL-17 levels >50 pg/mL in Psoriasis correlate with severe disease and predict treatment resistance to conventional therapies
- Environmental medicine assessment critical: chronic noise exposure >65 dB increases autoimmune disease risk 1.4-fold via sustained Cortisol elevation
- Infections trigger hyper-immune responses that can persist as autoimmunity: EBV in 99.5% of Multiple Sclerosis patients vs. 90% general population
- Psoriasis — model autoimmune disease demonstrating visible inflammatory plaques, IL-23/IL-17 axis, and keratinocyte hyperproliferation; responds to lifestyle interventions proving cPNI principles
- T cells — autoreactive T cells (both CD4+ and CD8+) drive tissue damage through IFN-γ, IL-17, and direct cytotoxicity in all autoimmune diseases
- Treg cells — CD4+CD25+FOXP3+ regulatory T cells fail to suppress autoreactive lymphocytes due to chronic stress, Cortisol resistance, and chronic inflammation
- B cells — produce autoantibodies (ACPA, anti-dsDNA, anti-TPO) that form immune complexes causing tissue damage via complement activation
- keratinocytes — show 3-4 day proliferation cycle (vs. 28 days normal) in Psoriasis driven by IL-17 and IL-22 from Th17 cells
- chronic low-grade inflammation — underlying state perpetuating autoimmune diseases through sustained TNF-α, IL-6, CRP elevation and Cytokine resistance
- AVP — chronically elevated from Dehydration activates V1a receptors causing vasoconstriction and hypertension in 40-60% of autoimmune patients
- infections — EBV, Porphyromonas gingivalis, Streptococcus trigger hyper-immune responses via Molecular Mimicry that evolve into chronic autoimmunity
- HPA axis — dysregulation causes Glucocorticoid Receptor resistance impairing Cortisol-mediated immune suppression, allowing unchecked autoimmune responses
- insular cortex — integrates peripheral immune signals via vagal afferents and modulates HPA/autonomic responses; dysfunction correlates with autoimmune disease severity
- Evolutionary mismatch — modern lifestyle factors (chronic stress, sedentary behavior, processed foods, circadian disruption) activate ancestral immune programs inappropriately
- gut microbiome — dysbiosis with reduced Akkermansia-muciniphila, Faecalibacterium prausnitzii impairs Treg cells induction and increases Intestinal permeability
- Intestinal permeability — breakdown of tight junctions allows LPS, food antigens, bacteria to translocate, maintaining chronic immune activation through TLR4 signaling
- environmental medicine — sensory environment (noise >65 dB, blue light at night, chemical exposures, air pollution) affects autoimmune disease activity via chronic stress pathways
- Down syndrome — Trisomy 21 causes immune gene dosage imbalance (chromosome 21 carries interferon receptors, SOD1) increasing autoimmune disease prevalence 50%
- rheumatoid arthritis — autoimmune joint disease driven by anti-Citrullinated proteins antibodies (ACPA) forming immune complexes that activate complement and destroy cartilage
- Multiple Sclerosis — autoimmune demyelinating disease with Th1/Th17 cells attacking Myelin Oligodendrocyte Glycoprotein in CNS; 99.5% associated with EBV infection
- Type 1 diabetes — autoimmune destruction of pancreatic beta cells by CD8+ T cells recognizing GAD65, insulin, and islet antigens via perforin/granzyme pathway
- Hashimoto's thyroiditis — autoimmune thyroid disease with anti-TPO and anti-thyroglobulin antibodies causing hypothyroidism via lymphocytic infiltration and gland destruction
- chronic stress — sustained Cortisol causes Glucocorticoid Receptor downregulation and Cytokine resistance, exacerbating autoimmune disease through loss of immunosuppression
- intermittent fasting — metabolic intervention reducing autoimmune inflammation via mTORC1 inhibition, Autophagy induction, and enhanced Resolution of inflammation
- cold exposure — hormetic stress activating brown adipose tissue, reducing TNF-α, increasing Adiponectin, and potentially modulating Th17/Treg balance
- Molecular Mimicry — pathogen epitopes sharing sequence homology with self-antigens (e.g., Streptococcus M protein vs. cardiac myosin) cause cross-reactive immune responses
- Citrullinated proteins — post-translational modification by PAD-4 converts arginine→citrulline creating neoantigens recognized by ACPA in rheumatoid arthritis
- TNF-α — central pro-inflammatory cytokine driving tissue damage in autoimmunity; chronic elevation >8 pg/mL indicates need for TNF-blocking interventions
- IL-6 — pleiotropic cytokine both pro-inflammatory (acute phase response) and regulatory (muscle-derived); dysregulation in autoimmunity causes Cytokine resistance
- IFN-γ — Th1 cytokine activating macrophages and upregulating MHC expression, amplifying autoimmune responses particularly in Multiple Sclerosis and Type 1 diabetes
- Module 1
- Module 2
- Module 3
- Module 4
- Module 5
- Module 6
- Module 7